biogen’s new alzheimer’s treatment: what to know
Published 1 year ago • 1.4K plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
4:40
eli lilly ceo discusses fda's approval of biogen's new alzheimer's drug
-
1:52
eisai-biogen's alzheimer's treatment drug receives fda approval
-
5:27
biogen gets fda approval for alzheimer's drug aduhelm which will cost $56,000 per year per patient
-
1:22
fda recommends biogen's alzheimer's drug for approval
-
7:21
fda ‘abandoned its responsibility’ in approving biogen alzheimer’s drug: doctor
-
36:12
alzheimer's fraud - the alleged fabrication in alzheimer's research and articles.
-
5:55
controversy around fda’s approval of biogen alzheimer’s drug, aducanumab
-
55:36
faces of lyme
-
1:50
medicare to restrict coverage of biogen’s alzheimer’s drug
-
5:51
biogen's alzheimer’s drug could generate ‘$8 billion in peak sales’: analyst
-
7:01
biogen alzheimer's drug may be 'first effort of a clear win': analyst
-
3:45
biogen stock soars on promising data from alzheimer’s drug trial
-
5:20
biogen alzheimer's drug: doctors 'won't come out of the gates prescribing' this: analyst
-
3:00
fda approves biogen-eisai alzheimer’s drug, china in talks to make pfizer paxlovid generic
-
3:23
biogen to buy rare-disease drugmaker reata in $7.3b deal
-
34:07
eli lilly ceo discusses covid-19 treatments, and biogen's fda approval of new alzheimer's drug
-
7:54
biogen ceo michel vounatsos on seeking fda approval for new alzheimer's drug
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
2:18
three fda members resign over biogen's alzheimer drug approval: rpt
-
3:31
fda approves controversial biogen alzheimer's drug | dw news
-
1:54
biogen shares fall after it scraps alzheimer's treatment
-
4:21
biogen soars on promising results from alzheimer's drug trial